Induction of angiotensin-converting enzyme with the ACE inhibitory compound MK-421 in rat lung
References (15)
- et al.
Captopril in the treatment of clinical hypertension and cardiac failure
Lancet
(1979) - et al.
Induction of angiotensin I-converting enzyme in rat lung with captopril (SQ 14225)
European J. Pharmacol.
(1980) - et al.
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor ‘MK-421’
Lancet
(1981) - et al.
Effects of captopril (SQ 14225) on the reninangiotensin-aldosterone system in normal rats
European J. Pharmacol.
(1980) Elevation of serum angiotensin converting enzyme (ACE) level in sarcoidosis
Am. J. Med.
(1975)- et al.
Protein measurement with foline phenol reagent
J. Biol. Chem.
(1951) - et al.
Plasma-converting enzyme activity does not reflect effectiveness of oral treatment with captopril
European J. Pharmacol.
(1981)
There are more references available in the full text version of this article.
Cited by (27)
Inhibition of either angiotensin-converting enzyme or neutral endopeptidase induces both enzymes
1994, European Journal of PharmacologyEffects of one-hour and one-week treatment with ramipril on plasma and renal brush border angiotensin converting enzyme in the rat
1993, European Journal of PharmacologySchistosoma mansoni: Angiotensin converting enzyme activity in mice under the influence of praziquantel and/or captopril
1991, Experimental ParasitologyAngiotensin-converting enzyme responses following enalapril in the sodium deficient rat
1986, European Journal of PharmacologyEffects of converting enzyme inhibitors: Ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart
1985, European Journal of PharmacologyTesticular angiotensin I-converting enzyme (E.C. 3.4.15.1)
1985, Life Sciences
Copyright © 1982 Published by Elsevier B.V.